Lipella Pharmaceuticals Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lipella Pharmaceuticals Inc. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $200.00K, a 4.14% decline year-over-year.
- Lipella Pharmaceuticals Inc. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $121.20K, a 59.43% decline year-over-year.
- Lipella Pharmaceuticals Inc. stock issued during period, value, issued for services for the quarter ending 2023-06-30 was $847.62K, a 297.03% increase year-over-year.
- Lipella Pharmaceuticals Inc. stock issued during period, value, issued for services for the quarter ending 2023-03-31 was $208.64K, a 11.27% decline year-over-year.
- Lipella Pharmaceuticals Inc. stock issued during period, value, issued for services for fiscal 2024 was $200.00K, a 65.02% increase from fiscal 2023.
- Lipella Pharmaceuticals Inc. stock issued during period, value, issued for services for fiscal 2023 was $121.20K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2024-12-31 | $200.00K 10-K · filed 2025-03-28 | |
| 2024-03-31 | $200.00K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $121.20K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $121.20K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $847.62K 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $208.64K 10-Q · filed 2023-11-14 | |
| 2022-09-30 | $298.76K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $213.49K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $235.15K 10-Q · filed 2023-11-14 |